Michael Wermann

1.5k total citations
31 papers, 1.1k citations indexed

About

Michael Wermann is a scholar working on Molecular Biology, Oncology and Biochemistry. According to data from OpenAlex, Michael Wermann has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Biochemistry. Recurrent topics in Michael Wermann's work include Glycosylation and Glycoproteins Research (8 papers), Amino Acid Enzymes and Metabolism (8 papers) and Peptidase Inhibition and Analysis (8 papers). Michael Wermann is often cited by papers focused on Glycosylation and Glycoproteins Research (8 papers), Amino Acid Enzymes and Metabolism (8 papers) and Peptidase Inhibition and Analysis (8 papers). Michael Wermann collaborates with scholars based in Germany, United States and Australia. Michael Wermann's co-authors include Hans‐Ulrich Demuth, Torsten Hoffmann, Hans‐Ulrich Demuth, Ulrich Heiser, Stephan Schilling, Leona Wagner, Holger Cynis, Michael H. Engel, Hans Brandstetter and R. Kiefersauer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Michael Wermann

30 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Wermann Germany 17 479 401 286 209 204 31 1.1k
Dale D. O. Martin Canada 20 1.1k 2.2× 149 0.4× 364 1.3× 151 0.7× 196 1.0× 36 1.7k
Gennaro Illiano Italy 18 710 1.5× 149 0.4× 116 0.4× 217 1.0× 125 0.6× 47 1.3k
Ronald J. Uhing United States 20 1.1k 2.3× 165 0.4× 207 0.7× 220 1.1× 75 0.4× 33 1.7k
Jean‐Pierre Abita France 19 660 1.4× 155 0.4× 139 0.5× 160 0.8× 53 0.3× 40 1.1k
Richard L. Soffer United States 21 1.1k 2.3× 280 0.7× 147 0.5× 141 0.7× 156 0.8× 37 1.5k
Maria Yang United States 22 929 1.9× 92 0.2× 104 0.4× 75 0.4× 121 0.6× 27 1.5k
Roger L. Hudgin Canada 15 1.2k 2.6× 234 0.6× 297 1.0× 217 1.0× 90 0.4× 16 1.8k
Lih-Ling Lin United States 15 1.1k 2.3× 129 0.3× 86 0.3× 218 1.0× 50 0.2× 17 1.5k
T D Chrisman United States 18 735 1.5× 75 0.2× 120 0.4× 201 1.0× 105 0.5× 22 1.2k
Mark W. Kunkel United States 21 748 1.6× 252 0.6× 107 0.4× 59 0.3× 78 0.4× 36 1.3k

Countries citing papers authored by Michael Wermann

Since Specialization
Citations

This map shows the geographic impact of Michael Wermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wermann more than expected).

Fields of papers citing papers by Michael Wermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Wermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wermann. The network helps show where Michael Wermann may publish in the future.

Co-authorship network of co-authors of Michael Wermann

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Wermann. A scholar is included among the top collaborators of Michael Wermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Wermann. Michael Wermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bayly-Jones, Charles, Hariprasad Venugopal, Michael Wermann, et al.. (2022). Helical ultrastructure of the metalloprotease meprin α in complex with a small molecule inhibitor. Nature Communications. 13(1). 6178–6178. 8 indexed citations
2.
Jäger, Christian, Dagmar Schlenzig, Michael Wermann, et al.. (2021). Structure and Dynamics of Meprin β in Complex with a Hydroxamate-Based Inhibitor. International Journal of Molecular Sciences. 22(11). 5651–5651. 9 indexed citations
3.
Wermann, Michael, et al.. (2018). Continuous assays for meprin alpha and beta using prolyl tripeptidyl aminopeptidase (PtP) from Porphyromonas gingivalis. Analytical Biochemistry. 559. 11–16. 7 indexed citations
4.
Schlenzig, Dagmar, Holger Cynis, Maike Hartlage‐Rübsamen, et al.. (2018). Dipeptidyl-Peptidase Activity of Meprin β Links N-truncation of Aβ with Glutaminyl Cyclase-Catalyzed pGlu-Aβ Formation. Journal of Alzheimer s Disease. 66(1). 359–375. 19 indexed citations
5.
Schlenzig, Dagmar, et al.. (2015). Expression, purification and initial characterization of human meprin β from Pichia pastoris. Protein Expression and Purification. 116. 75–81. 11 indexed citations
6.
Koch, Birgit, Mirko Buchholz, Michael Wermann, et al.. (2012). Probing Secondary Glutaminyl Cyclase (QC) Inhibitor Interactions Applying an in silico‐Modeling/Site‐Directed Mutagenesis Approach: Implications for Drug Development. Chemical Biology & Drug Design. 80(6). 937–946. 11 indexed citations
7.
Wagner, Leona, Michael Wermann, Fred Rosche, et al.. (2011). Isolation of dipeptidyl peptidase IV (DP 4) isoforms from porcine kidney by preparative isoelectric focusing to improve crystallization. Biological Chemistry. 392(7). 665–77. 3 indexed citations
8.
Stephan, Anett, Michael Wermann, Alex von Bohlen, et al.. (2009). Mammalian glutaminyl cyclases and their isoenzymes have identical enzymatic characteristics. FEBS Journal. 276(22). 6522–6536. 36 indexed citations
9.
Hartlage‐Rübsamen, Maike, Alexander Waniek, Michael Wermann, et al.. (2009). Developmental expression and subcellular localization of glutaminyl cyclase in mouse brain. International Journal of Developmental Neuroscience. 27(8). 825–835. 26 indexed citations
10.
Schilling, Stephan, Torsten Hoffmann, Holger Cynis, et al.. (2008). Inhibition of glutaminyl cyclase prevents pGlu‐Aβ formation after intracortical/hippocampal microinjection in vivo/in situ. Journal of Neurochemistry. 106(3). 1225–1236. 68 indexed citations
11.
Cynis, Holger, Jens‐Ulrich Rahfeld, Anett Stephan, et al.. (2008). Isolation of an Isoenzyme of Human Glutaminyl Cyclase: Retention in the Golgi Complex Suggests Involvement in the Protein Maturation Machinery. Journal of Molecular Biology. 379(5). 966–980. 64 indexed citations
12.
Friedrich, Daniel, Torsten Hoffmann, Michael Wermann, et al.. (2007). Does human attractin have DP4 activity?. Biological Chemistry. 388(2). 155–162. 15 indexed citations
13.
Schilling, Stephan, Irene Stenzel, Alex von Bohlen, et al.. (2007). Isolation and characterization of the glutaminyl cyclases from Solanum tuberosum and Arabidopsis thaliana: implications for physiological functions. Biological Chemistry. 388(2). 145–53. 24 indexed citations
14.
Schilling, Stephan, Birgit Koch, Michael Wermann, et al.. (2007). Isolation and Characterization of Glutaminyl Cyclases from Drosophila:  Evidence for Enzyme Forms with Different Subcellular Localization. Biochemistry. 46(38). 10921–10930. 20 indexed citations
15.
Schilling, Stephan, André J. Niestroj, Jens‐Ulrich Rahfeld, et al.. (2003). Identification of Human Glutaminyl Cyclase as a Metalloenzyme. Journal of Biological Chemistry. 278(50). 49773–49779. 78 indexed citations
16.
Weber, Ann E., T. Hoffmann, Jiří Štork, et al.. (2003). Characterisation of Human Dipeptidyl Peptidase IV Expressed in Pichia pastoris. A Structural and Mechanistic Comparison between the Recombinant Human and the Purified Porcine Enzyme. Biological Chemistry. 384(12). 1553–63. 20 indexed citations
17.
Schilling, Stephan, Torsten Hoffmann, Michael Wermann, et al.. (2002). Continuous Spectrometric Assays for Glutaminyl Cyclase Activity. Analytical Biochemistry. 303(1). 49–56. 50 indexed citations
18.
19.
Heilig, B., Michael Wermann, H. Gallati, et al.. (1992). Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis. Journal of Molecular Medicine. 70(1). 22–27. 52 indexed citations
20.
Wermann, Michael, et al.. (1992). Is soluble CD25 antigen (interleukin-2 receptor) a useful parameter for differential diagnosis of thyrotoxicosis?. Journal of Molecular Medicine. 70(2). 122–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dale D. O. Martin Breakdown of academic impact, for papers by Gennaro Illiano Breakdown of academic impact, for papers by Ronald J. Uhing Breakdown of academic impact, for papers by Jean‐Pierre Abita Breakdown of academic impact, for papers by Richard L. Soffer Breakdown of academic impact, for papers by Maria Yang Breakdown of academic impact, for papers by Roger L. Hudgin Breakdown of academic impact, for papers by Lih-Ling Lin Breakdown of academic impact, for papers by T D Chrisman Breakdown of academic impact, for papers by Mark W. Kunkel
Rankless by CCL
2026